Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus Among Pregnant Refugees and Turkish Women: A Retrospective Comparative Study

Altunal, Lütfiye Nilsun

doi:10.14744/scie.2018.66375

Cited by 7 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[30] When the studies on rubella virus seroprevalence in pregnant women in Turkey were evaluated, the lowest rubella IgG positivity with a rate of 86.6% was in Van and the highest seropositivity with a rate of 97.5% was in Isparta (Table 1). [14,17,20,22,23,28,[31][32][33][34][35][36] In this study, rubella IgG seropositivity rate which is 91.7% was a little lower than that of regional data, however, it is consistent with overall data in our country. Our results reveal that there is a rubella virus-responsive pregnant with a rate of 8%.…”

Section: Discussionsupporting

confidence: 83%

“…[37] In studies on CMV IgG seropositivity rates in pregnant women in Turkey, the rate was generally more than 90% (Table 1). [14,[20][21]23,28,[32][33][34][35][38][39][40] In this study, while CMV IgG seropositivity was 99.3%, IgM seropositivity was 14.7%. These results reveal that most of the women of childbearing age face CMV before pregnancy.…”

Section: Discussionmentioning

confidence: 91%

See 1 more Smart Citation

Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections in Pregnant Women

Albayrak¹

2020

Anatol JFM

View full text Add to dashboard Cite

Primary infection agents occurring during pregnancy and causing congenital anomalies are Toxoplasma gondii (T.gondii), rubella virus and cytomegalovirus (CMV). It was revealed that these agents infected the fetus by crossing the placenta and increased the rate of fetal morbidity and mortality. This study aimed to investigate the relationship between seroprevalences of T. gondii, rubella virus and CMV antibodies. Methods:The results were retrospectively evaluated. Pregnant women's serum samples sent to the Medical Microbiology Laboratory of Ankara Gülhane Training and Research Hospital between January 2018 and December 2018 were included in this study. T. gondii, rubella virus and CMV IgM and IgG antibodies were analysed using the chemiluminescent immunoassay method.Results: In this study, the results of 647 pregnant patients were retrospectively analysed. The median age of the attendants was 28.0 (18.0-49.0) years. IgM positivities for T. gondii, rubella virus and CMV were found as 3 (0.6%), 3 (0.5%) and 61 (15.0%) respectively and IgG positivities were 66 (13.8%), 529 (91.7%) and 394 (99.3%), respectively. Conclusion:In this study, the results were consistent with the findings obtained in the regional studies. Seroprevalence studies in pregnant women will be guide for the necessity of prenatal screening tests. Therefore, the findings suggest that pregnant women and women of childbearing age should be investigated concerning T. gondii, the rubella virus and CMV antibodies.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Discussionmentioning

confidence: 91%

Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections in Pregnant Women

Albayrak¹

2020

Anatol JFM

View full text Add to dashboard Cite

show abstract

“…These lower results may be attributed to the life style of Eritrean women, like consumption of properly heated and cooked food, and less contact with domestic animals. We found the prevalence of TORCH IgG to be much lower compared to the results of studies that were conducted in Saudi Arabia, India and Turkey [3][4][5][6]11,12 .…”

Section: Discussioncontrasting

confidence: 68%

Seroprevalence of TORCH in women with spontaneous abortion and stillbirth, in Asmara, Eritrea

Adgoy¹,

Elfatih²,

Elhadi³

et al. 2020

Popul. Med.

View full text Add to dashboard Cite

INTRODUCTION Toxoplasma gondii, others, rubella, cytomegalovirus and herpes simplex (all together denoted as TORCH) are the major causes of bad obstetric history (BOH) and may cause birth defects. Therefore, antenatal screening for antibodies to TORCH infectious agents is an important tool for diagnosis. Thus, the study was conducted to determine the seroprevalence of TORCH among mothers with a loss of pregnancy (abortion) or stillbirth. METHODS A laboratory-based cross-sectional study on the frequency and associated risk factors for the prevalence of TORCH was conducted from 28 February to 31 March 2018. The study included 44 women aged 18-45 years who were admitted at Orotta Maternity National Referral and Teaching Hospital, Asmara, Eritrea, due to loss of pregnancy (abortion) or stillbirth. The study participants were selected by systematic random sampling. From each woman, 3 mL of venous blood was collected in a container with aseptic technique. Immunoglobulin G antibodies against Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex were detected by IgG Combo Rapid Test Cassette (Serum). RESULTS Of the 44 mothers with mean age of 29.3 years (SD=5.6), who were tested by IgG Combo Rapid Test Cassette

show abstract

“…In our study, we determined the anti-Toxoplasma IgG and anti-Toxoplasma IgM seropositivities in pregnant women as 36.3% and 1.0%, respectively. According to different studies conducted in Turkey, anti-toxoplasma IgG positivity was found between 30.1% and 69.5% (6,(7)(8)(9). The overall rate of seropositivity for T. gondii antibodies has been reported to reach as high as 85% In Turkey (11).…”

Section: Discussionmentioning

confidence: 99%

“…The overall rate of seropositivity for T. gondii antibodies has been reported to reach as high as 85% In Turkey (11). In recent research in Istanbul, toxoplasma seropositivity was detected between 31% and 26.3% in pregnant women (7,9). Toxoplasmosis prevalence varies in different parts of the world.…”

Section: Discussionmentioning

confidence: 99%

Gebe kadınlarda Toxoplasma, Rubella, Sitomegalovirüs ve Herpes Simpleks Virus Tip 2 serum antikorlarının sıklığı

Güzel¹

2020

Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi

View full text Add to dashboard Cite

Infections during pregnancy are one of the causes of morbidity and mortality for mother and fetus. TORCH are the microorganisms that cause congenital infections. Prevention and treatment of TORCH infection is very important for maternal and child health. In this study, we aimed to determine the seroprevalence of these infections among pregnant women. Material and Methods: Laboratory data of 1371 pregnant women were evaluated retrospectively. Toxoplasma, Rubella and Cytomegalovirus IgM and IgG antibodies were tested by the carbonylmetalloimmunoassay method. Results: The ages of pregnant women whose laboratory data were examined, varied between 17 and 47, and the mean age was 30.1 ± 5.2. Positive Toxoplasma IgG antibody was found 36.3%, while 1.0% were positive for the Toxoplasma IgM antibody. Rubella IgG seropositivity was found 94.3%, and Rubella IgM was found 0.7%. CMV IgG and IgM positivities were detected in 94.1% and 0.9% respectively. Conclusion: Detection of antenatal risk groups is an important step in the prevention of congenital syndromes. Therefore, it is very important to know the seropositivity rates of that region. The common population screening may contribute to the prevention of congenital infections due to TORCH agents. Toxoplasma gondii screening can be recommended because the prevalence is not high. CMV screening is not significant due to high seroprevalence. High anti-rubella IgG seropositivity shows that pregnant women in this region have high immunity levels.

show abstract

Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus Among Pregnant Refugees and Turkish Women: A Retrospective Comparative Study

Cited by 7 publications

References 23 publications

Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections in Pregnant Women

Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections in Pregnant Women

Seroprevalence of TORCH in women with spontaneous abortion and stillbirth, in Asmara, Eritrea

Gebe kadınlarda Toxoplasma, Rubella, Sitomegalovirüs ve Herpes Simpleks Virus Tip 2 serum antikorlarının sıklığı

Contact Info

Product

Resources

About